|
HS Code |
236378 |
| Generic Name | Sotalol |
| Brand Names | Betapace, Sorine, Sotylize |
| Drug Class | Antiarrhythmic (Class III) and non-selective beta-blocker |
| Molecular Formula | C12H20N2O3S |
| Primary Use | Treatment of certain types of cardiac arrhythmias |
| Route Of Administration | Oral, Intravenous |
| Bioavailability | 90-100% (oral) |
| Half Life | 12-20 hours |
| Mechanism Of Action | Blocks beta-adrenergic receptors and potassium channels |
| Common Side Effects | Bradycardia, fatigue, dizziness, dyspnea, QT prolongation |
| Contraindications | Bronchial asthma, sinus bradycardia, second or third-degree AV block, congenital or acquired long QT syndromes |
| Pregnancy Category | Category B |
| Protein Binding | Low (<5%) |
| Renal Excretion | Predominantly unchanged in urine |
As an accredited Sotalol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sotalol packaging features a white and blue box, labeled “Sotalol 80mg,” containing 100 film-coated tablets with dosage instructions. |
| Shipping | Sotalol is shipped in tightly sealed, clearly labeled containers to prevent contamination and ensure safety. It must be stored at controlled room temperature, protected from light and moisture. Proper documentation, including Material Safety Data Sheets (MSDS), accompanies the shipment. Handling follows regulatory guidelines for pharmaceutical chemicals to guarantee compliance and secure delivery. |
| Storage | Sotalol should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It must be kept in a tightly closed container, protected from light and moisture. Store away from incompatible materials and out of reach of children. Do not freeze. Ensure storage areas are secure to prevent unauthorized access or accidental exposure. |
|
Purity 99%: Sotalol with a purity of 99% is used in ventricular arrhythmia management, where enhanced antiarrhythmic efficacy is achieved. Molecular Weight 272.37 g/mol: Sotalol at a molecular weight of 272.37 g/mol is utilized in atrial fibrillation control, where predictable pharmacokinetics ensure consistent dosing. Stability Temperature 25°C: Sotalol with a stability temperature of 25°C is applied in hospital pharmacy compounding, where chemical integrity is maintained under standard storage conditions. Enantiomeric Excess 98%: Sotalol with enantiomeric excess 98% is employed in pediatric cardiology, where reduced risk of enantioselective side effects is observed. Bulk Density 0.58 g/cm³: Sotalol with a bulk density of 0.58 g/cm³ is used in tablet formulation, where uniform compaction and accurate dosing are ensured. Solubility 70 mg/mL (water): Sotalol with solubility 70 mg/mL in water is used in injectable preparations, where rapid dissolution supports immediate therapeutic action. Melting Point 163°C: Sotalol with a melting point of 163°C is used in high-temperature sterilization processes, where compound stability is preserved. |
Competitive Sotalol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Managing irregular heartbeat brings plenty of worry for patients and families alike. Medications shape everyday life and, in some ways, expectations for the future. Sotalol, a medication used to treat certain types of abnormal heart rhythms, has grown into a regular part of many people’s lives. Whether you or a loved one has felt the jolt of a racing heart or the confusion that comes with unfamiliar palpitations, knowing more about what’s available—and how each option functions—helps start honest conversations between patients and health professionals.
Sotalol belongs to a group of medicines called beta blockers, but unlike most standard beta blockers, it also works as a potassium channel blocker. This dual action sets it apart, both in its effect on the heart’s rhythm and the way it’s approached in practice. For many, this difference means sotalol acts as both a brake and a conductor for the heart’s electrical system—slowing certain nerves and helping organize the rhythm at the same time.
Pharmacies usually carry sotalol as tablets in different strengths, like 80 mg and 160 mg. The medication comes in solid doses, easy to count and take as prescribed. Unlike some other rhythm drugs that might require complex compounding or hard-to-swallow liquids, sotalol’s design considers routine use in daily life. One of the more noticeable details: sotalol’s absorption in the body isn’t greatly set off by meals, so patients do not have to fuss about timing doses with food. This may sound minor, but, from experience, medications that can be taken with or without meals fit better into unpredictable schedules.
Doctors usually recommend sotalol to adults and children with specific types of arrhythmia, especially those known as ventricular arrhythmias and atrial fibrillation. Over the years, research and clinical practice have brought sotalol closer to the front of the line for people who cannot tolerate other options or when other treatments do not fully control heart rhythm problems. Its effect is not just about slowing the pulse—sotalol lengthens the interval between the electrical signals that trigger each heartbeat. This effect, measured as the QT interval on an EKG, gives the heart muscle extra time to reset itself before the next squeeze.
These actions sound technical, but they matter in plain language because they lower the chance of dangerous or life-threatening rhythms. Fainting, dizzy spells, and even sudden cardiac arrest shrink as risks with well-managed treatment.
Plenty of medicines fall under the rhythm-control umbrella. Amiodarone, flecainide, propafenone, and dofetilide all treat specific arrhythmias. Yet sotalol has a reputation for balance. It does not come with the same risk of pulmonary toxicity as amiodarone—a well-known concern for anyone with a lengthy treatment plan. Nor does it carry the extra burden on the liver or thyroid. Sotalol’s metabolism mainly takes place in the kidneys, which is why doctors watch kidney function carefully.
Early studies and real-world use show that sotalol produces fewer nervous system side effects than some drugs, helping people continue to work, drive, or care for children without constant brain fog. Sticking to a medication over the long haul matters more than most people realize. Patients who start and stop medications for any reason—side effects, unpredictability, tricky routines—struggle to see the pay-off in stable heart rhythms.
Doctors choose sotalol for patients with certain arrhythmias. Those whose hearts beat too fast (as in atrial fibrillation) or have dangerous extra beats (as in ventricular tachycardia) become likely candidates, especially when other treatments have failed or caused problems. Children and adults both find a place for sotalol in current research and modern practice.
People with asthma or certain lung problems may not be the best fit due to the way sotalol affects airway muscles. For older adults or people with kidney issues, the care team watches dose and lab results closely. No one wants to trade one health problem for another, so the risk of a longer QT interval (sometimes pushing the heart into a different type of dangerous rhythm called torsades de pointes) keeps doctors on their toes.
Pregnancy and breastfeeding require extra discussion. Studies continue, and doctors weigh risks and benefits before reaching a decision. The stakes feel higher for expectant moms and parents caring for infants, so transparency and strong, factual conversations shape better choices.
Taking sotalol calls for regular follow-ups and shared decision-making. Doctors want to spot abnormal rhythms before they cause trouble. That means occasional EKGs and bloodwork are not just red tape. Early changes, picked up by the care team, help avoid bigger problems. Many patients grow used to the routine: quick visits, tracing heartbeats, looking for patterns, catching side effects before they land.
Common issues with sotalol include feeling tired, cold hands and feet, and sometimes mild digestive upset. Anyone starting sotalol learns about these possibilities up front. More serious issues, although less common, deserve mention: slow heart rate, significant drops in blood pressure, and, as mentioned, a longer QT interval. I remember talking with patients who worried about the long list of risks on the medication pamphlet—hearing the actual numbers and the doctor’s experience made a world of difference.
Patients or caregivers should feel empowered to speak up. Dizziness, fainting, or unexplained shortness of breath always deserve a call to the healthcare team. Education matters here: people who understand what to expect stick with treatment and catch problems early.
Choices around rhythm medications spark heated debate among heart specialists. Amiodarone, for instance, brings high power with serious risks—lung, liver, thyroid, and eye problems can add up over time. Propafenone and flecainide suit those with no structural heart damage but can worsen outcomes for people recovering from a heart attack or valve problem.
Sotalol stands out because it gets the job done without requiring frequent inpatient monitoring like some alternatives. Unlike dofetilide, for instance, sotalol rarely needs a hospital stay just to start the medicine, at least for those with normal heart function and lab numbers. Regular monitoring in the doctor’s office, a routine most patients can work into their schedules, keeps things simple and safe.
Budget matters, too. Some rhythm-control drugs break the bank, force insurance appeals, or require prior authorizations that delay treatment. Sotalol, available as a generic for years, means a lower cost for most families. In an economy where drug prices and out-of-pocket costs create fear and anger, access and affordability add up to peace of mind.
Sotalol does not live on the sidelines. People set phone alarms, keep spare tablets in their bags, and sometimes navigate tricky coworker questions about “that blue pill.” As the person who sits across from patients describing weekly routines, I see what adds up to a sustainable treatment. Flexibility, predictable side effects, and straightforward instructions help people blend treatment into everyday life. Sotalol’s twice-daily dosing schedule fits the breakfast-and-dinner rhythm most people already follow.
For parents, especially those caring for children with inherited rhythm problems, knowing that a medication remains safe, effective, and well-tolerated encourages participation in sports, travel, and normal life. My experience in pediatric heart clinics taught me that families rally around what works, not just what sounds promising on paper. Sotalol gives the kind of reliability that builds confidence and lets families loosen their grip just a little on fear.
Staying healthy with sotalol depends on more than swallowing a pill. Patients who keep regular appointments fare better because early signs of trouble get picked up and corrected. For those struggling to keep up with monitoring or transportation, telehealth and remote monitoring options bridge gaps—sending EKG strips or symptoms lists through secure apps keeps the communication lines open.
In clinics serving rural areas or low-income communities, access issues sometimes block regular care. Outreach programs and nurse check-ins work as a lifeline for many. Pharmacies offering medication counseling give a second set of eyes and ears, reinforcing instructions and helping prevent confusion or mistakes. From my own experience, a five-minute pharmacy conversation has saved more than a few ER visits.
Side effects cause stress for patients. For those facing persistent tiredness, clinicians talk through adjusting timing, supportive treatments (like more fluids or salt in the diet), and look for drug interactions. Sotalol’s lack of interaction with most food or over-the-counter medications gives families flexibility at the dinner table and in daily routines. Still, certain situations call for added caution—dehydration, sudden illness, or surgery may throw things off, and honest reporting during doctor’s visits keeps care on track.
Rhythm medications get plenty of attention as science pushes forward—but cost, storage, and the sheer challenge of living with chronic heart disease force doctors and patients to look beyond the latest breakthrough. A medication may look ideal in a trial, but real-world life means juggling work, stress, schedules, and other pills. Sotalol’s straightforward profile and decades of safety data give it staying power across age groups and practice settings.
As community health resources expand, more patients learn about their choices. Social workers, pharmacists, and nurse educators play a growing part in safe medication use. Sotalol, familiar to most professionals, fits within nurse-led education sessions, school medication plans for children, and primary care follow-up without requiring constant intervention by specialists. Reducing bottlenecks helps families focus on living, not just surviving.
Changing technology enhances safety. Home EKG machines make monitoring QT intervals from the living room possible—no cold waiting rooms, just a few clicks and the data reach the specialist. This shift affects sotalol use, opening access and encouraging timely checks for patients scattered geographically or with transportation hurdles. Clear, step-by-step teaching brings out the strengths of such technology; patients need ongoing support, not just a stack of instructions.
No single medication answers every need for every patient. Sotalol has carved out a role through predictable results, a lower risk profile than many alternatives, and a user-friendly format. Physicians continue to weigh kidney function, other health problems, lifestyle, and personal wishes as part of a bigger plan. Sometimes families must switch to another medication—unacceptable side effects, limited benefit, or new health worries can all prompt change. In these cases, I’ve seen that honest feedback and shared decision-making beat any one-size-fits-all protocol.
Patients and caregivers do not need to settle for confusion or uncertainty. Conversations work best in clear, respectful language—setting facts against worries, bringing together clinical evidence and lived experience. This is true for anyone trying to make sense of their options, whether for arrhythmia, blood pressure, or any other condition that demands long-term commitment.
As more comes to light about genetic risk, personal cardiac profiles, and tailored medicine, sotalol may find new roles or face new competition. Until then, its history of steady support for people with heart rhythm disorders speaks loudly. The medication’s blend of scientific rigor, practical use, and day-to-day tolerability has carried countless patients through the tough days and let them focus on what matters—living well beyond a diagnosis.
Heart rhythm disorders carry more than physical symptoms—they reshape relationships, work opportunities, and peace of mind. Sotalol offers a tool for many, built on decades of experience and constant updates as new science comes in. For families and patients, open questions should never become barriers. Each new answer means more control, fewer surprises, and, for some, a feeling of hope when it matters most.
Checking in with a healthcare team regularly, speaking up about changes or concerns, and reaching out for help with insurance or pharmacy access pay off. Strong partnerships between patients and providers produce the most reliable results—and sotalol, with its track record of safety and effectiveness, serves as a reminder that the right medication can be more than a prescription. It can be a lifeline, a companion, and a quiet piece of security in everyday life.